Medical Xpress September 3, 2024
University of Texas at Austin

Researchers have discovered an antibody able to neutralize all known variants of SARS-CoV-2, the virus that causes COVID-19, as well as distantly related SARS-like coronaviruses that infect other animals.

As part of a new study on hybrid immunity to the virus, the large, multi-institution research team led by The University of Texas at Austin discovered and isolated a broadly neutralizing plasma antibody, called SC27, from a single patient. Using technology developed over several years of research into antibody response, the team led by UT engineers and scientists obtained the exact molecular sequence of the antibody, opening the possibility of manufacturing it on a larger scale for future treatments.

“The discovery of SC27, and other antibodies like it in the future,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Govt Agencies, Healthcare System, Patient / Consumer, Provider, Public Health / COVID, Survey / Study, Trends
Exercise Intolerance Is Common Among People With Persistent Long Covid: Study
‘Quad-demic’ Hitting U.S. With Flu, COVID-19, RSV, Norovirus Surging
The CIA believes COVID most likely originated from a lab but has low confidence in its own finding
President Trump’s First Week Hammered Public Health
Bill Gates says the odds of another pandemic in the next 4 years are 10%-15%, and we’re not prepared

Share This Article